Psychopharmacology (Berl). 2019 Nov 29. doi: 10.1007/s00213-019-05391-0. [Epub ahead of print]
Moreton SG1, Szalla L2, Menzies RE3, Arena AF3.
Author information
1School of Psychology, University of Wollongong, Wollongong, NSW, 2522, Australia. smoreton@uow.edu.au.2School of Psychology, University of Wollongong, Wollongong, NSW, 2522, Australia.3School of Psychology, University of Sydney, Camperdown, NSW, 2006, Australia.
Abstract
Psychedelic therapies can engender enduring improvements in psychological well-being. However, relatively little is known about the psychological mechanisms through which the salutary effects of psychedelics emerge. Through integrating extant research on psychedelics with contemporary existential psychology, we present a novel hypothesis that reduced death anxiety may be a key mechanism underpinning the therapeutic effects of psychedelics. In developing this hypothesis, we also provide a complementary review of mechanisms through which psychedelics may reduce death anxiety. We conclude that an awareness of the role of death anxiety in psychopathology has the potential to guide future research into psychedelic therapies.
KEYWORDS:
DMT; Death anxiety; Fear of death; LSD; Psilocybin; Psychedelic therapy; Psychedelics; TransdiagnosticPMID: 31784805 DOI: 10.1007/s00213-019-05391-0